National Bank of Canada’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.8K | Buy |
3,483
+459
| +15% | +$11.2K | ﹤0.01% | 1511 |
|
|
2025
Q1 | $62.8K | Hold |
3,024
| – | – | ﹤0.01% | 1515 |
|
|
2024
Q4 | $71.2K | Sell |
3,024
-1,131
| -27% | -$26.6K | ﹤0.01% | 1492 |
|
|
2024
Q3 | $106K | Buy |
4,155
+920
| +28% | +$23.6K | ﹤0.01% | 1345 |
|
|
2024
Q2 | $75.9K | Buy |
3,235
+159
| +5% | +$3.73K | ﹤0.01% | 1418 |
|
|
2024
Q1 | $76.6K | Buy |
3,076
+146
| +5% | +$3.64K | ﹤0.01% | 1439 |
|
|
2023
Q4 | $95.8K | Sell |
2,930
-395
| -12% | -$12.9K | ﹤0.01% | 1421 |
|
|
2023
Q3 | $89.4K | Buy |
3,325
+400
| +14% | +$10.8K | ﹤0.01% | 1438 |
|
|
2023
Q2 | $99.7K | Sell |
2,925
-109
| -4% | -$3.72K | ﹤0.01% | 1441 |
|
|
2023
Q1 | $91.3K | Sell |
3,034
-86,280
| -97% | -$2.6M | ﹤0.01% | 1429 |
|
|
2022
Q4 | $2.52M | Buy |
89,314
+16,956
| +23% | +$479K | 0.01% | 741 |
|
|
2022
Q3 | $2.37M | Buy |
72,358
+41,137
| +132% | +$1.35M | 0.01% | 654 |
|
|
2022
Q2 | $983K | Sell |
31,221
-277,155
| -90% | -$8.73M | ﹤0.01% | 865 |
|
|
2022
Q1 | $14.2M | Sell |
308,376
-154,672
| -33% | -$7.11M | 0.04% | 286 |
|
|
2021
Q4 | $28.4M | Buy |
+463,048
| New | +$28.4M | 0.1% | 150 |
|